Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma.
J Clin Invest. 2022 Jan 18;132(2):e150535. doi: 10.1172/JCI150535.
J Clin Invest. 2022.
PMID: 34813506
Free PMC article.
Clinical Trial.